Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Tangible Net Worth Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Tangible Net Worth Ratio of 95.3% as of March 2026. This metric is calculated by deducting intangible assets (CN¥360.37 Million) from net assets (CN¥7.74 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shanghai Allist Pharmaceuticals Co. Ltd. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shanghai Allist Pharmaceuticals Co. Ltd. A Tangible Net Worth Ratio (2017–2025)
This chart shows how Shanghai Allist Pharmaceuticals Co. Ltd. A's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 95.3%, reflecting net assets of CN¥7.74 Billion with intangible assets of CN¥360.37 Million CNY. See 688578 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of Shanghai Allist Pharmaceuticals Co. Ltd..
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.6% | CN¥14.40 Billion | CN¥349.63 Million | CN¥7.90 Billion | ▲ +2.0 pp |
| 2024 | 95.6% | CN¥5.28 Billion | CN¥232.42 Million | CN¥5.92 Billion | ▼ -2.7 pp |
| 2023 | 98.3% | CN¥3.98 Billion | CN¥66.49 Million | CN¥4.38 Billion | ▲ +0.5 pp |
| 2022 | 97.9% | CN¥3.19 Billion | CN¥68.45 Million | CN¥3.44 Billion | ▲ +0.1 pp |
| 2021 | 97.7% | CN¥2.97 Billion | CN¥67.29 Million | CN¥3.13 Billion | ▲ +0.1 pp |
| 2020 | 97.6% | CN¥2.88 Billion | CN¥69.18 Million | CN¥2.99 Billion | ▲ +3.4 pp |
| 2019 | 94.2% | CN¥1.18 Billion | CN¥68.35 Million | CN¥1.33 Billion | ▲ +5.9 pp |
| 2018 | 88.3% | CN¥71.04 Million | CN¥8.31 Million | CN¥375.00 Million | ▼ -11.3 pp |
| 2017 | 99.6% | CN¥381.26 Million | CN¥1.60 Million | CN¥508.63 Million | — |